|
|
Volumn 9, Issue 1, 2009, Pages 63-64
|
|
Public health issues with counterfeit medicines
a
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ANTITHROMBOCYTIC AGENT;
ATORVASTATIN;
ILLICIT DRUG;
NEUROLEPTIC AGENT;
DRUG EFFICACY;
DRUG LEGISLATION;
DRUG MARKETING;
DRUG PACKAGING;
DRUG SAFETY;
HEALTH PRACTITIONER;
INDUSTRIALIZATION;
NOTE;
PHARMACEUTICAL CARE;
PRESCRIPTION;
PUBLIC HEALTH SERVICE;
STANDARDIZATION;
UNITED KINGDOM;
WORLD HEALTH ORGANIZATION;
|
|
EID: 63449130030
PISSN: 14702118
EISSN: 14734893
Source Type: Journal
DOI: 10.7861/clinmedicine.9-1-63 Document Type: Note |
|
Times cited : (7)
|
|
References (4)
|
